ENTRY       D00326                      Drug
NAME        Fluoxetine (USAN/INN);
            Fluoxetine (TN)
FORMULA     C17H18F3NO
EXACT_MASS  309.134
MOL_WEIGHT  309.3261
CLASS       Neuropsychiatric agent
             DG01659  Selective serotonin reuptake inhibitor (SSRI)
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      ATC code: N06AB03
            Chemical structure group: DG00942
            Product (DG00942): D00823<US>
EFFICACY    Antidepressant, Selective serotonin reuptake inhibitor (SSRI)
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
  PATHWAY   hsa04726(6532)  Serotonergic synapse
METABOLISM  Enzyme: CYP2C9 [HSA:1559], CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP2C19 [HSA:1557], CYP2D6 [HSA:1565], CYP3A [HSA:1576 1577 1551]
            Transporter inhibition: ABCB1 [HSA:5243]
STR_MAP     map07027  Antidepressants
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AB Selective serotonin reuptake inhibitors
                 N06AB03 Fluoxetine
                  D00326  Fluoxetine (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00942  Fluoxetine
                D00326  Fluoxetine
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00942  Fluoxetine
                D00326  Fluoxetine
              DG01644  CYP2D6 substrate
               DG00942  Fluoxetine
                D00326  Fluoxetine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00942  Fluoxetine
                D00326  Fluoxetine
              DG01645  CYP2D6 inhibitor
               DG00942  Fluoxetine
                D00326  Fluoxetine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00942  Fluoxetine
                D00326  Fluoxetine
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG00942  Fluoxetine
                D00326  Fluoxetine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D00326  Fluoxetine (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00326
             Drug transporters
              D00326
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00942  Fluoxetine
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00942  Fluoxetine
              DG01644  CYP2D6 substrate
               DG00942  Fluoxetine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00942  Fluoxetine
              DG01645  CYP2D6 inhibitor
               DG00942  Fluoxetine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00942  Fluoxetine
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG00942  Fluoxetine
DBLINKS     CAS: 54910-89-3
            PubChem: 7847392
            ChEBI: 5118
            LigandBox: D00326
            NIKKAJI: J244.937D
ATOM        22
            1   C1c C    19.5445  -17.2645
            2   C8y C    19.5445  -18.6727
            3   O2a O    20.7718  -16.5573
            4   C1b C    18.3175  -16.5573
            5   C8x C    18.3117  -19.3799
            6   C8x C    20.7658  -19.3799
            7   C8y C    21.9931  -17.2645
            8   C1b C    17.1021  -17.2585
            9   C8x C    18.3117  -20.7938
            10  C8x C    20.7658  -20.7938
            11  C8x C    21.9931  -18.6727
            12  C8x C    23.2144  -16.5573
            13  N1b N    15.8748  -16.5515
            14  C8x C    19.5445  -21.5010
            15  C8x C    23.2085  -19.3799
            16  C8x C    24.4357  -17.2645
            17  C1a C    14.6535  -17.2585
            18  C8y C    24.4357  -18.6786
            19  C1d C    25.6568  -19.3856
            20  X   F    26.9717  -20.0226
            21  X   F    26.2471  -18.3863
            22  X   F    24.9673  -20.5193
BOND        23
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     4   8 1
            8     5   9 2
            9     6  10 1
            10    7  11 2
            11    7  12 1
            12    8  13 1
            13    9  14 1
            14   11  15 1
            15   12  16 2
            16   13  17 1
            17   15  18 2
            18   18  19 1
            19   19  20 1
            20   19  21 1
            21   19  22 1
            22   10  14 2
            23   16  18 1
///
